Brain Tumors

Infratentorial Craniotomy

Survival: Infratentorial Craniotomy

The 30- and 180-day survival rates for intratentorial craniotomy were 100% and 96%, respectively (for the first 6 months of 2018).

Inpatient Mortality: Infratentorial Craniotomy

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality. solutions.3m.com/wps/portal/3M/en_US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software.

There have been only 3 deaths in patients undergoing infratentorial craniotomy at Cleveland Clinic in the past 5 years, which is below the expected number based on national averages. N = number of infratentorial craniotomies performed for brain tumor per year.

Average Length of Stay: Infratentorial Craniotomy

LOS = length of stay

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality. solutions.3m.com/wps/portal/3M/en_US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software.

Average length of stay has remained lower than predicted over the past 5 years.

KPS Status-Percent Change (N=26)

2018

Performance status was stable or improved in 97% of patients undergoing infratentorial craniotomy. Functional status is measured by the Karnofsky Performance Scale, a widely used 11-point scale correlating to percentage values from 100% (no evidence of disease, no symptoms) to 0% (death). Change in status was defined as a change of ≥ 20 points.

Survival: Infratentorial Craniotomy for Glioma

Thirty-day survival for infratentorial craniotomy for glioma, metastases, meningioma, and Schwannoma was 100% (for the first 6 months of 2018).

Survival: Infratentorial Craniotomy for Meningioma

Thirty-day survival for infratentorial craniotomy for glioma, metastases, meningioma, and Schwannoma was 100% (for the first 6 months of 2018).

Survival: Infratentorial Craniotomy for Metastasis

Thirty-day survival for infratentorial craniotomy for glioma, metastases, meningioma, and Schwannoma was 100% (for the first 6 months of 2018).

Survival: Infratentorial Craniotomy for Schwannoma

Thirty-day survival for infratentorial craniotomy for glioma, metastases, meningioma, and Schwannoma was 100% (for the first 6 months of 2018).